Phân tích ABC, VEN và ma trận ABC-VEN được thực hiện để xác định các loại thuốc cần kiểm soát quản lý nghiêm ngặt. Sở Y tế thực hiện chủ trương ngành y tế đấu thầu tập trung cho các cơ sở y tế trong tỉnh để tìm các nguồn cung cấp có chất lượng đáp ứng nhu cấu điều trị an toàn hiệu quả. | 22 PHÂN TÍCH ABC VEN KẾT QUẢ ĐẤU THẦU THUỐC NĂM 2015 2016 VÀ 2017 CỦA SỞ Y TẾ AN GIANG Từ Hoàng Tước Nguyễn Duy Tân Trần Quang Hiền Nguyễn Thiện Tri Abstract ABC VEN analysis based on the results of bidding for drugs in An Giang Department of Health in the years from 2015 to 2017 Objective Analysis of the drug list of the Department of Health An Giang in 2015 2016 and 2017 based on ABC VEN analysis for selection drug to be used pre-post intervention. Methods A descriptive study based on the ABC VEN matrix conducted an economic analysis of the 3-year used of An Giang s medical facilities. Results Annual drug expenditure in 2015 2016 and 2017 was respectively VND VND VND of which 265 229 and 283 were classified in group A was respectively accounting for 70 1 70 1 70 0 of the cost of using drugs. Group B was respectively 315 281 322 accounted for 19 9 19 9 cost of drug use and group C was respectively 713 674 684 drugs 55 1 56 9 53 1 accounted for only 10 0 of the cost of using drugs each year in health facilities. VEN analysis in 2015 2016 and 2017 showed that group V is respectively 155 149 and 133 drugs 12 0 12 6 10 3 accounting for 15 9 15 2 13 8 of the cost of using drugs the group E is respectively 969 drugs 82 5 81 8 84 1 accounted for 78 5 78 4 78 8 of costs of using drugs and the group N was respectively 71 66 72 drugs 5 5 5 6 5 6 accounted for 5 6 6 3 7 4 of the cost of using drugs charge for non-essential drugs. Category I AV BV AE AN drugs was respectively 373 341 374 in the ABC VEN matrix analysis in 2015 2016 and 2017 accounted for of the cost of using drugs. Category II BE CE BN was respectively 882 805 879 types 68 2 68 0 68 2 accounted for and 23 respectively 2 9 3 2 2 8 accounted for of the cost of using drugs. Category I medication was closely monitored for better yearly drug use control and .
